10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2010 | ||
CONSOLIDATED BALANCE SHEETS | ||
Period Ending Dec 31, 2010 10-K (Filed: Feb 18, 2011) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2010 | Dec 31, 2009 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 5,033 | 7,683 |
| Marketable securities | 2,268 | 831 |
| Receivables | 3,480 | 3,164 |
| Inventories | 1,204 | 1,413 |
| Deferred income taxes | 1,036 | 611 |
| Prepaid expenses | 252 | 256 |
| Total Current Assets | 13,273 | 13,958 |
| Property, plant and equipment | 4,664 | 5,055 |
| Goodwill | 5,233 | 5,218 |
| Other intangible assets | 3,370 | 2,865 |
| Deferred income taxes | 850 | 1,636 |
| Marketable securities | 2,681 | 1,369 |
| Other assets | 1,005 | 907 |
| Total Assets | 31,076 | 31,008 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term borrowings | 117 | 231 |
| Accounts payable | 1,983 | 1,711 |
| Accrued expenses | 2,740 | 2,785 |
| Deferred income | 402 | 237 |
| Accrued rebates and returns | 857 | 622 |
| U.S. and foreign income taxes payable | 65 | 175 |
| Dividends payable | 575 | 552 |
| Total Current Liabilities | 6,739 | 6,313 |
| Pension, postretirement and postemployment liabilities | 1,297 | 1,658 |
| Deferred income | 895 | 949 |
| U.S. and foreign income taxes payable | 755 | 751 |
| Other liabilities | 424 | 422 |
| Long-term debt | 5,328 | 6,130 |
| Total Liabilities | 15,438 | 16,223 |
| Commitments and contingencies (Note 26) | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 5,269 in 2010 and 5,515 in 2009, liquidation value of $50 per share | ||
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2010 and 2009 | 220 | 220 |
| Capital in excess of par value of stock | 3,682 | 3,768 |
| Accumulated other comprehensive loss | (2,371) | (2,541) |
| Retained earnings | 31,636 | 30,760 |
| Less cost of treasury stock - 501 million common shares in 2010 and 491 million in 2009 | (17,454) | (17,364) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 15,713 | 14,843 |
| Noncontrolling interest | 75 | 58 |
| Total Equity | 15,638 | 14,785 |
| Total Liabilities and Equity | 31,076 | 31,008 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |